Job description
Scorpion Therapeutics is a precision oncology company founded in February 2020 by a preeminent group of scientists from Harvard University/Massachusetts General Hospital – Keith Flaherty, MD, Gaddy Getz, Ph.D. and Liron Bar-Peled, Ph.D. The company has raised $270M in Series A and Series B financings led by blue-chip investors, including Atlas Venture, Boxer Capital of Tavistock Group, EcoR1 Capital, LLC, Omega Funds, and Vida Venture.
Scorpion Therapeutics' mission is to serve oncology patients by discovering and developing best-in-class and first-in-class, small molecule cancer medicines that address large patient segments with significant unmet medical needs. To accomplish this mission, we are building a highly collaborative team focused on the pursuit of novel approaches to small molecule drug discovery. This approach relies upon dynamic collaboration between cancer biology, proteomics, informatics, structural biology and medicinal chemistry – with the ultimate goal of realizing the full potential of targeted/precision oncology.
The successful candidate will have a proven track record of working in the ADME/DMPK area supporting R&D programs. They will have experience with working in a highly collaborative team environment, interfacing with multiple departments across the organization and developing strategic relationships with preferred vendors. They will work closely with other nonclinical disciplines such as toxicology and bioanalytical, and ensure that nonclinical objectives for programs are achieved.
Key Responsibilities
- Design and coordinate nonclinical studies to understand the pharmacokinetics and absorption, metabolism, distribution, and excretion of molecules
- Represent DMPK in multifunctional discovery and development project teams, for the collaborative optimization of compound design and project Design/Make/Test cycles, and for development candidate profiling
- Collaborate with other functions, but particularly pharmacology and toxicology to select appropriate preclinical toxicology species, establish/refine PK-PD efficacy/safety relationships and provide human dose predictions
- Ensure that appropriate DMPK studies are included in program plans and timelines
- Responsible for the analysis, interpretation, integration, and reporting of preclinical DMPK data
- Contribute to the cross-functional review of regulatory documents and author and review DMPK sections for relevant regulatory documents e.g. IND, IB, and be accountable for their quality in support of regulatory submissions
- Serve as a subject matter expert in composing responses to regulatory queries
- Identify, qualify, engage, and manage external providers of in vitro ADME and in vivo PK services; analyze and interpret resulting data
- Provide in-depth scientific expertise and technical leadership as well as resource and relationship management of external networks
- Deliver and communicate results to project teams and other stakeholders to enable decision making
- Recommend, initiate, lead and champion new innovations from external, global and local sources to ensure cutting-edge science is applied to drug project issues
Professional Experience and Qualifications
- PhD or equivalent in a relevant scientific discipline
- A minimum of 10+ years of discovery and development experience in pharmaceutical/biotech R&D supporting ADME/PK
- Strong knowledge of drug metabolism, ADME concepts, pharmacokinetics, pharmacodynamic and bioanalytical principles
- Hands on experience with in vitro and vivo ADME/PK studies and an in-depth understanding of study design, data interpretation and how ADME/PK studies contribute to the discovery and development process
- Experience working with external vendors to provide ADME/PK support for programs
- Highly developed written and verbal communication skills, including ability to effectively articulate highly technical/complex scientific data and concepts to audiences with differing scientific and technical knowledge
- Up to date knowledge on regulatory guidance related to ADME/PK characterization, drug-drug interactions
- Experience designing and critically evaluating results of exploratory and GLP-compliant studies
- Team player with strong negotiation, problem-solving, and strategic influencing skills
- Strong customer focus with the ability to have robust discussions with project leaders and other stakeholders to ensure that project, scientific and resource demands are aligned
- Track record of successful problem solving, high quality science and influencing of stakeholders, particularly in a drug project context
#LI-SR1
Scorpion Therapeutics Inc. is an Equal Opportunity Employer who strives to create and maintain a diverse working environment. We do not discriminate for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Beginning October 13, 2021, Scorpion Therapeutics requires all new hires to be fully vaccinated against COVID-19. If you are unable to receive the vaccine due to a disability or serious medical condition, or because of your sincerely held religious beliefs, you will have an opportunity to request a reasonable accommodation.
learninglandscape.com is the go-to platform for job seekers looking for the best job postings from around the web. With a focus on quality, the platform guarantees that all job postings are from reliable sources and are up-to-date. It also offers a variety of tools to help users find the perfect job for them, such as searching by location and filtering by industry. Furthermore, learninglandscape.com provides helpful resources like resume tips and career advice to give job seekers an edge in their search. With its commitment to quality and user-friendliness, learninglandscape.com is the ideal place to find your next job.